Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell renal carcinoma: a case study - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Pathology Année : 2022

Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell renal carcinoma: a case study

Résumé

The dynamics of metastatic evolution in clear cell renal cell carcinoma (ccRCC) are complex. We report a case study where tumour heterogeneity resulting from clonal evolution is a frequent feature and could play a role in metastatic dissemination.We used an integrative multiomics strategy combining genomic and transcriptomic data to classify fourteen specimens from spatially different areas of a kidney tumour and three non-primary sites including a vein thrombus and two adrenal metastases.All sites were heterogeneous and polyclonal, each tumour site containing two different aggressive subclonal populations, with differentially expressed genes implicated in distinct biological functions. These are rare primary metastatic samples prior to any medical treatment, where we showed a multiple metastatic seeding of two subclonal populations.Multiple interdependent lineages could be the source of metastatic heterogeneity in ccRCC. By sampling metastases, patients with resistance to therapies could benefit a combination of targeted therapies based on more than one aggressive clone.
Fichier principal
Vignette du fichier
Dagher et al - R1 -Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell (1).pdf (1.58 Mo) Télécharger le fichier
Table S1 - R1 - FC.xlsx (371.77 Ko) Télécharger le fichier
Table S2 - R1 - FC.xlsx (81.79 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03217234 , version 1 (28-09-2021)

Identifiants

Citer

Julien Dagher, Angelique Brunot, Bertrand Evrard, Solene-Florence Kammerer-Jacquet, Marion Beaumont, et al.. Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell renal carcinoma: a case study. Journal of Clinical Pathology, 2022, 75, pp.426-430. ⟨10.1136/jclinpath-2020-207326⟩. ⟨hal-03217234⟩
183 Consultations
180 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More